PRIMARY STUDY

Enhanced Oral Bioavailability of β-Caryophyllene in Healthy Subjects Using the VESIsorb® Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS)

Key Findings:  This study measured the oral bioavailability of β-Caryophyllene (BCP) in a self-emulsifying drug delivery system (SEDDS) when given to healthy subjects. It was deemed safe and well-tolerated, and the SEDDS system effectively increased the bioavailability BCP.